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AbstrAct
Objective To perform a systematic literature review 
(slr) about the effect of non- pharmacological 
interventions delivered by non- physician health 
professionals to prevent and manage osteoporotic 
fractures.
Methods eight clinical questions based on two criteria 
guided the slr: (1) adults≥50 years at high risk of 
osteoporotic fracture and (2) interventions delivered 
by non- physician health professionals to prevent and 
manage osteoporotic fractures. interventions focused 
on diagnostic procedures to identify risk of falling, 
therapeutic approaches and implementation strategies. 
Outcomes included fractures, falls, risk of falling and 
change in bone mineral density. systematic reviews and 
randomised controlled trials were preferentially selected. 
Data were synthesised using a qualitative descriptive 
approach.
Results Of 15 917 records, 43 articles were included. 
studies were clinically and methodologically diverse. We 
identified sufficient evidence that structured exercise, 
incorporating progressive resistance training delivered 
to people who had undergone hip fracture surgery, 
and multicomponent exercise, delivered to people 
at risk of primary fracture, reduced risk of falling. 
The effectiveness of multidisciplinary fracture liaison 
services in reducing refracture rate was confirmed. 
There was insufficient evidence found to support 
the effectiveness of nutrients and falls prevention 
programmes in this patient population.
Conclusion Despite study heterogeneity, our slr 
showed beneficial effects of some interventions 
delivered by non- physician health professionals and the 
positive impact of multidisciplinary team working and 
patient educational approaches to prevent and manage 
osteoporotic fractures. These results informed a eUlar 
taskforce that developed points to consider for non- 
physician health professionals to prevent and manage 
osteoporotic fractures.
InTROduCTIOn
By 2040, an estimated 319 million adults aged 
50 years or more worldwide will be at high 
risk of osteoporotic fracture.1 While Asian 
populations will carry much of this burden, 
other nationalities, including European, will 
see risk rise. The morbidity, mortality and cost 
associated with osteoporotic fractures, and the 
availability of effective pharmacological treat-
ments for prevention and management,2–4 
highlight the importance of identification 
and treatment of ‘high- risk’ individuals. Yet, 
Key messages
What is already known about this subject?
 ► non- pharmacological interventions delivered by 
non- physician health professionals to prevent and 
manage osteoporotic fractures are increasingly 
important.
What does this study add?
 ► The literature about common non- pharmacological 
interventions delivered by non- physician health 
professionals to prevent and manage osteoporotic 
fractures in adults 50 years or older is synthesised 
and presented.
 ► evidence about the effect of many non- 
pharmacological interventions delivered by non- 
physician health professionals to reduce fragility 
fractures remains limited.
How might this impact on clinical practice?
 ► This systematic literature review informed a task-
force to develop eUlar points to consider for 
non- physician health professionals to prevent and 
manage fragility fractures in adults 50 years or older.
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Table 1 Definitions used by the taskforce to identify 
studies that included individuals at high risk of osteoporotic 
fracture
Osteopenia T score ≤−1.0 to −2.5 SD
Osteoporosis T score ≤−2.5 SD
FRAX 10- year probability of a 
major* osteoporotic fracture
≥20% (age independent)
FRAX 10- year probability of 
hip fracture
≥3% (age independent)
FRAX NOGG threshold 40–90 years (age 
dependent)
T score, unit of SD from the mean for bone mineral density 
compared with a healthyyoung adult.
FRAX intervention thresholds vary between countries.
*A clinical spine, hip, forearm or humerus fracture.
FRAX, Fracture Risk Assessment Tool; NOGG, National 
Osteoporosis Guideline Group.
current healthcare provision is insufficient and many 
people at high risk of osteoporotic fracture are neither 
identified nor receive treatment.5–7
Alongside pharmacological agents, non- 
pharmacological interventions, such as exercise, fall 
prevention measures and adequate intake of key nutri-
ents, are important in the prevention and management 
of osteoporosis.8–10 Two previous systematic reviews 
reported some evidence that interventions delivered 
by dietitians, nurses, physiotherapists and pharmacists, 
working alone or in multidisciplinary teams, can posi-
tively influence health- related outcomes for people 
with, or at risk of osteoporosis, including quality of life 
(QoL), calcium intake, medication compliance and bone 
mineral density (BMD) testing.11 12
Yet, despite evidence for the effectiveness of interven-
tions provided by non- physician health professionals 
(HPs), implementation may be suboptimal in many coun-
tries. Arguably, there is scope for greater involvement of 
non- physician HPs in primary and secondary fracture 
prevention. Recent recommendations by the EULAR and 
European Federation of National Associations of Ortho-
paedics and Traumatology are available to guide physi-
cians in the management of patients 50 years and older 
with a recent fragility fracture and prevention of subse-
quent fractures,13 and updated European guidance exists 
to streamline healthcare for diagnosis and management 
of osteoporosis in postmenopausal women.14 However, 
international recommendations for non- physician HPs 
are lacking.
To address this gap, a commissioned taskforce has 
developed the first EULAR points to consider for non- 
physician HPs in the prevention and management of 
fragility fractures in adults 50 years or older. A systematic 
literature review (SLR) was undertaken to inform the 
development of these points to consider.
MeTHOds
We aimed to identify and appraise the up- to date scien-
tific literature about the effect of non- pharmacological 
interventions delivered by non- physician HPs to prevent 
and manage osteoporotic fracture in high- risk adults, age 
50 years or more. High risk of osteoporotic fracture was 
categorised using BMD values for low bone mass (osteo-
penia) and osteoporosis specified by WHO,15 and/or 
short- term probability of fracture. The definition we used 
for high- risk adults is detailed in table 1.
The aim of this SLR was to inform an international 
EULAR taskforce on a broad range of issues related to 
non- physician HPs’ interventions. Non- physician HPs 
deliver different interventions in different countries. 
Therefore, we focused our review on interventions 
that could potentially be delivered by non- physician 
HPs, independent of whether a study was led by a non- 
physician HP or not.
A SLR for each of eight clinical questions (table 2), 
formulated and consensually agreed by the taskforce, 
was undertaken by a research fellow (NW) with guidance 
from the taskforce convenors (EH, JA) and a method-
ologist (TAS). The methods for each SLR, including 
the research question and inclusion/exclusion criteria, 
were agreed on and documented within a joint taskforce 
meeting. The taskforce comprised 2 patient research part-
ners, 1 dietitian, 1 geriatrician and 1 nurse, 3 occupational 
therapists, 2 orthopaedic surgeons, 4 physiotherapists, 1 
specialist in physical medicine and rehabilitation and 5 
rheumatologists, drawn from 10 European countries.
The conduct of the review was informed by Cochrane 
principles.16 A Participants, Interventions, Comparisons, 
Outcomes and Study design approach17 was adopted 
for each question followed by a systematic search across 
international electronic databases (Medline/PubMed, 
Embase and Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) for relevant literature 
published between January 2007 and October 2017 
(online supplementary file 1). Searches were based on 
two critieria: (1) adults≥50 years of age at high risk of 
primary or secondary osteoporotic fracture and (2) inter-
ventions delivered by non- physician HPs to prevent and 
manage osteoporotic fractures. Interventions included 
diagnostic procedures to identify risk of falling, thera-
peutic approaches (eg, structured exercise, education, 
falls prevention programmes) and implementation strat-
egies. Key outcomes were fractures and falls (where the 
accepted definition of a fall was an unexpected event 
in which the participants come to rest on the ground, 
floor or lower level18). High risk of falling and change in 
BMD were included as surrogate end points. Fractures in 
adults age ≥50 years were assumed to be fragility fractures 
unless at the ankle, hands and feet, skull and face,19 or as 
a result of high- intensity trauma.
study selection
Following removal of duplicates, two review authors 
(NW and EH) independently selected eligible studies 
and achieved consensus on which articles to include. 
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Table 2 Clinical questions
1 Which diagnostic procedures, undertaken by non- physician health professionals (HPs), are recommended in the 
assessment of risk of falling in adults at high risk of primary or secondary osteoporotic fracture?
2 What is the effect (including cost- effectiveness and safety) of non- pharmacological treatments provided by non- 
physician HPs after osteoporotic fracture?
3 What is the effect (including cost- effectiveness and safety) of non- pharmacological treatments provided by non- 
physician HPs in adults at high risk of primary osteoporotic fracture?
4 What is the effect of strategies undertaken by non- physician HPs to implement recommendations for the 
prevention and management of osteoporotic fracture by potential stakeholders?
5 What is the effect of multi- disciplinary team care on health outcomes for persons at high risk of primary or 
secondary osteoporotic fracture?
6 What is the effect of interventions provided by non- physician HPs to enhance adherence to antiosteoporosis 
medicines in adults at high risk of primary or secondary osteoporotic fracture?
7 What is the remit of the rheumatology review as undertaken by non- physician HPs with respect to bone health 
across all rheumatic conditions?
8 What bone health education should non- physician HPs deliver to people with rheumatic disease, specifically 
younger adults (up to 50 years of age)?
Publications investigating interventions commonly 
undertaken by non- physician HPs were included even 
if the professional group delivering the intervention 
was not specifically stated or non- physician HPs were 
not sole providers. Articles were excluded if published 
in languages other than English. Systematic reviews and 
randomised controlled trials (RCTs) were preferen-
tially selected, although (quasi) randomised and non- 
randomised studies were included. Systematic reviews 
with sufficient quality were considered to cover the time 
until their search ended. Studies with small sample sizes 
(<50 participants) were excluded.
data extraction and quality assessment
Data, including research design, population charac-
teristics, interventions and outcomes were extracted by 
the research fellow from all selected articles describing 
diagnostic procedures, therapeutic approaches and 
implementation strategies. Systematic reviews were eval-
uated using AMSTAR 2—A MeaSurement Tool to Assess 
systematic Reviews,20 while risk of bias (RoB) judgements 
about primary studies followed a domain- based assess-
ment as recommended by the Cochrane collaboration.21 
We characterised a ‘partial Yes’ response in a critical 
domain of AMSTAR 2 as a non- critical weakness. Risk of 
performance bias was considered unclear in studies in 
which blinding of participants and/or personnel was not 
feasible. Evidence was classified in accordance with the 
Oxford Centre for Evidence- based- Medicine 2011 Levels 
of Evidence,22 but upgraded or downgraded in response 
to methodological strengths and weaknesses.
data synthesis
Evidence about the effect of interventions was synthe-
sised descriptively and rated using four categories: 
sufficient; some; insufficient; and insufficient evidence 
to determine, as described by Ryan et al23 (see online 
supplementary file 1, table 1). Studies describing mixed 
populations (participants with and without osteoporotic 
fracture) were allocated based on the proportion of 
participants with fracture, that is, if >50% of the popula-
tion had at least one fragility fracture, the study was allo-
cated to question 2; if ≤50%, the study was allocated to 
question 3. If more than one published article reported 
data from a single cohort, the most up- to- date publica-
tion was included in the analysis.
ResulTs
The database searches yielded 15 917 citations. Following 
removal of duplicates, we screened 11 195 titles and or 
abstracts. Two hundred and eighteen full- text articles 
were selected for review, of which 182 were rejected. 
Seven additional studies were identified from other 
sources, for example, the reference lists of selected publi-
cations. No articles were found to answer questions 7 and 
8. Subsequently, 43 articles were included in data analysis 
and synthesis (figure 1).
Data were extracted from 1 review of systematic reviews, 
17 systematic reviews, 1 narrative review, 20 RCTs, one 
quasi- RCT and 3 non- randomised studies. Meta- analyses 
for outcomes of interest were available in 9 papers,24–32 
with participant numbers from 11624 to 19 519.25 Sample 
size of primary studies varied from 6229 participants33 to 
70 participants.34 Four studies had a sample size of fewer 
than 100 participants.34–37
Overall confidence in systematic review findings was 
high in two reviews,26 38 but low or critically low in the 
remainder (online supplementary file 1, table 2). Assess-
ment of RoB of primary randomised studies showed 
that eight were at unclear RoB due to issues affecting 
methods of randomisation, while allocation concealment 
was unclear in over half of the studies. Nearly 50% of the 
included studies were at high or unclear risk of detection 
bias while seven studies were considered at risk of attri-
tion bias. Recruitment and allocation concealment were 
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Figure 1 Flow diagram of articles included in the 
systematic literature review. PICOS, Participants, 
Interventions, Comparisons, Outcomes and Study design.
assessed as unclear in the non- randomised studies. Anal-
ysis was via intention to treat in 60% of the RCTs included 
in this SLR, although this was interpreted differently 
across studies. Eleven RCTs were adequately powered for 
the outcome of interest.
Clinical questions
Which diagnostic procedures, undertaken by non-physician hPs, 
are recommended in the assessment of risk of falling in adults at 
high risk of primary or secondary osteoporotic fracture?
Evidence about diagnostic procedures to assess risk of falls 
was extracted from one narrative review.39 The Stopping 
Elderly Accidents, Deaths and Injuries algorithm incor-
porates a stepped approach to falls risk screening, assess-
ment and intervention, and is recommended for use. Key 
initial screening questions help to identify people who 
have fallen in the past year, feel unsteady or are fearful of 
falling. Responses guide further assessment. Subsequent 
screening, if required, includes the Timed Up and Go 
Test,40 with the Four- Stage Balance Test,41 the Five- Times 
Sit- to- Stand Test42 and other components of a multi-
factorial risk assessment if indicated. Recommended 
components include: a detailed falls history; medicines 
consumption and environmental and social factors asso-
ciated with risk of falling; footwear and home hazards; 
evaluation of bodily systems, for example, via blood pres-
sure monitoring; Fracture Risk Assessment Tool; and 
assessment of cognition and mental health. Although 
multiple tools are available to support the assessment of 
constituent factors associated with risk of falls, no specific 
tool is recommended, thereby reflecting the need for an 
individually tailored assessment.
What is the effect (including cost effectiveness and safety) of non-
pharmacological treatments provided by non-physician hPs after 
osteoporotic fracture?
The evidence for this question clustered around (1) exer-
cise, (2) nutrients including vitamin D plus calcium and 
oral nutritional supplements, (3) orthoses and (4) fall 
prevention programmes (table 3).
Exercise
Three meta- analyses and two RCTs contributed to the 
evidence synthesis about the effect of exercise on bone 
health- related outcomes in people who had experienced 
a vertebral fracture,27 any osteoporotic fracture43 or had 
undergone hip fracture surgery.28 29 35 Interventions 
included structured exercise of different types,28 balance 
training43 and progressive resistance exercise (PRE).29 35 
Outcomes included factors associated with risk of falls, for 
example, mobility, knee- extension strength and balance.
After hip fracture surgery, structured exercise, in 
particular interventions incorporating PRE for 2–3 
months, led to statistically significant improvements in 
mobility compared with usual care or no intervention 
(standardised mean difference (SMD)=0.501, 95% CI 
0.297 to 0.705; p<0.001).29 Balance and leg strength were 
also favourably affected by the intervention, although 
one RCT showed that PRE, in addition to routine phys-
iotherapy delivered between postoperative days 2 and 8, 
was not advantageous when compared with routine phys-
iotherapy alone.35 For people with vertebral fractures, 
structured exercise compared with usual daily activities 
reduced reports of pain and improved QoL, but did not 
improve risk of falling.27 However, the number of trials 
and participants available for pooling in meta- analysis 
was small.
Nutrients including vitamin D plus calcium and oral nutritional 
supplements
The effect of vitamin D supplementation on fractures 
and falls in people with a history of osteoporotic fracture 
was investigated in a Cochrane review subgroup analysis26 
and one RCT.44 Pooled data from 6134 participants (2737 
taking daily vitamin D (800 IU) plus calcium (1000 mg) 
for a minimum of 12 months) showed no significant 
difference between the intervention and control groups 
for subsequent risk of hip fracture (risk ratio 1.02, 95% CI 
0.71 to 1.47; p=0.26) or any fracture (risk ratio 0.93, 
95% CI 0.79 to 1.10; p=0.84). Fracture outcomes were 
also unaffected by a single loading dose of vitamin D3 
administered to older adults within 7 days of hip fracture 
surgery.44 In this trial, participants received either chole-
calciferol (250 000 IU) or a placebo injection in addition 
to supplementation with daily oral vitamin D (800 IU) 
and calcium (500 mg). Falls rate at 4 weeks was signifi-
cantly lower in the intervention group compared with the 
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placebo group (6.3% vs 21.2%; χ2=4.327; p=0.024), even 
though there was no statistically significant improvement 
in gait velocity.
Additionally, one small RCT investigated the effect of 
an oral nutritional supplement (containing 18–24 g of 
protein and 500kcal) versus usual care on factors asso-
ciated with risk of falls in older adults following hip frac-
ture surgery.45 However, at 4 weeks post discharge, there 
were no statistically significant differences in the Elderly 
Mobility Scale.
Orthoses
One systematic review of randomised and non- 
randomised studies investigated the effect of spinal 
orthoses in the management of people with osteoporotic 
vertebral fracture (OVF).38 Twelve studies with mainly 
small sample sizes and at RoB showed mixed results. No 
recommendations could be made about the use of spinal 
orthoses in people with an acute OVF (0–3 months), 
although complications from the use of rigid orthoses 
and casting, including falls and fractures, were reported. 
Three studies, incorporating 220 participants with a suba-
cute OVF, reported wearing a semirigid brace for several 
hours a day for 6 months improved back extensor and 
abdominal strength, reduced postural sway and thoracic 
kyphosis angle compared with an inactive control group. 
Thoracolumbar corsets in women with no acute OVF 
but a history suggestive of fracture were not supported. 
A single trial,37 in which custom foot orthoses or no 
orthoses were worn by persons with a history of verte-
bral or non- vertebral osteoporotic fracture, reported a 
positive impact on balance favouring the intervention. 
However, this study was at high risk of detection bias.
Falls prevention programmes
One systematic review investigating fear of falling in 
patients following hip fracture included four studies 
comparing the effect of interventions such as home reha-
bilitation and community exercise with conventional 
care or a control group.46 Two studies showed a statis-
tically significant reduction in fear of falling, measured 
by the Falls Efficacy Scale,47 48 although both had small 
sample sizes. An additional five studies34 49–52 investigated 
the effect of single and multicomponent fall prevention 
interventions in older adults who had undergone hip frac-
ture surgery. Data about falls occurring after discharge 
from hospital were collated during face- to- face or tele-
phone interviews in four studies and by a daily calendar 
diary in one study. Follow- up took place between 4 and 
24 months. All of the studies had relatively small sample 
sizes and three were at high risk of detection bias.
Of the single interventions, neither a brief telephone 
call targeted towards reducing falls made by an occu-
pational therapist to participants postdischarge,49 nor a 
6- week programme of treadmill walking focused towards 
visually guided stepping in relation to obstacles,34 
resulted in a statistically significant reduction in the 
proportion of fallers or the rate of falls when compared 
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with a control group. In contrast, a single home visit 
undertaken by an occupational therapist50 led to a lower 
proportion of fallers in the intervention group compared 
with a control group (OR 0.275, 95% CI 0.081 to 0.937; 
p=0.039). However, this was a quasi- RCT at unclear risk 
of selection bias.
Evidence for the effect of multicomponent interven-
tions, incorporating inpatient geriatric care, rehabilita-
tion and home assessment, and falls hazard reduction in 
older adults following hip surgery, also revealed mixed 
outcomes.51 52 One RCT based in Taiwan, in which partic-
ipants received in- home rehabilitation for 3 months post 
discharge, reported a lower occurrence of falls in non- 
cognitively impaired participants in the first 2 years after 
discharge compared with a control group (OR=0.47, 
95% CI 0.25 to 0.86; p=0.014).52 This benefit was not seen 
in participants with cognitive impairment. In contrast, 
Berggren et al51 found no statistically significant differ-
ence in fall incidence between groups at 1 year following 
a similar multifactorial falls- prevention programme 
(incidence rate ratio (IRR) 0.64, 95% CI 0.40 to 1.02; 
p=0.063), although there was a trend favouring the inter-
vention. In this study, postdischarge rehabilitation was 
provided if needed.
What is the effect (including cost effectiveness and safety) of non-
pharmacological treatments provided by non-physician hPs in 
adults at high risk of primary osteoporotic fracture?
One systematic review,53 three meta- analyses24 30 31 and 
three primary studies54–56 contributed evidence about 
exercise interventions. Two RCTs explored falls preven-
tion programmes36 57 and two systematic reviews58 59 and 
one RCT60 investigated nutrient supplementation. One 
systematic review explored patient education strategies61 
(table 4).
Exercise
Evidence from seven publications was synthesised to 
investigate the effect of exercise on risk of falling,30 31 53 
BMD,24 30 53 incidence rate of fractures54 56 and falls.53 55 
Available evidence from one meta- analysis31 suggests that 
multimodal exercise can reduce risk of falling in partic-
ipants at high risk of primary osteoporotic fracture 
compared with a control group, through improvements in 
mobility (SMD=−0.56, 95% CI −0.81 to 0.32) and balance 
(SMD=0.5, 95% CI 0.27 to 0.74). Likewise, regular multi-
modal exercise incorporating weight- bearing aerobic 
exercise and resistance training undertaken for ≥1 year 
appears to confer positive benefits on BMD,53 55 unlike 
whole- body vibration30 and low impact mind- body condi-
tioning exercise.24
Two primary studies,54 56 one randomised and one non- 
randomised, reported fewer fractures in women with low 
bone mass undertaking regular long- term multimodal 
exercise at least twice a week compared with a control 
group. Korpelainen et al54 stated a fracture IRR of 0.68 
(95% CI 0.34 to 1.32) following analysis of 7- year data 
collected from a national hospital discharge register 
and hospital records, while Kemmler et al56 reported a 
rate ratio of 0.42 (95% CI 0.20 to 0.86) drawing on data 
gathered via questionnaires and interviews. The effect of 
exercise on falls incidence was variable.53 55 In one study, 
the number of fallers increased following a 12- month 
multimodal exercise intervention, although the mecha-
nism for this is unclear.55
Nutrients including vitamin D plus calcium and oral nutritional 
supplements
Publications described nutritional supplementation with 
vitamin D analogues,58 protein59 and vitamin K.60 Change 
in BMD was the primary outcome in all studies and was 
assessed between 9 weeks and 48 months. One study60 
reported fracture incidence as a secondary outcome. All 
study participants were women. Data synthesis showed 
that supplementation with vitamin D analogues (alfacal-
cidol and 2- methylene-19- nor- (20S)−1α,25- dihydroxyvi
tamin D3 (2MD)) and daily vitamin K1 (5 mg), had no 
positive impact on BMD when assessed between 6 and 
48 months. Evidence for the effect of protein interven-
tions was limited and the findings were contradictory. 
Two high- quality RCTs included in a systematic review 
by Koutsofta et al59 reported no significant change in 
BMD from daily consumption of dietary non- soy protein 
(>90 g/day) or whey isolate supplement (30.1 g in 250 mg 
supplement) for 24 months when compared with control 
groups. Results from three other RCTs in the review were 
conflicting. In one study, total body BMD reduced after 
8 weeks of dietary supplementation, while in another, 
it increased at 24 months. The remaining RCT in the 
review reported improvement in total body BMD but not 
at other sites following 12- month supplementation with 
dietary protein and supplement (86 g/day including 6 g 
whey protein isolate). The sample size in all of these trials 
was small and the quality assessment rating was low.59
Falls prevention programmes
Two RCTs,36 57 one of which randomised over 1000 partic-
ipants,57 evaluated the effect of a multicomponent falls 
prevention programme compared with usual care on rate 
of falls in community dwelling older adults with osteopo-
rosis, and/or other risk factors for fall and fracture. The 
Nijmegen Falls Prevention Programme, conducted over 
5 and a half weeks, included training in falls techniques 
and correction of gait abnormalities, while the 12- month 
Chaos Clinic Falls Prevention Programme provided indi-
vidualised interventions, for example, a medicines review 
and referral to other specialists. Exercise and education 
were key components in both programmes and dropout 
rates were low, suggesting good acceptability to partici-
pants.
Both studies reported a significantly lower fall rate in 
the intervention group compared with the control group 
at 12 months. Smulders et al36 recorded a 39% reduction 
in falls per person years (IRR 0.61, 95% CI 0.40 to 0.94), 
while Palvanen et al57 reported a 28% reduction in falls 
per 100 person years (IRR 0.72, 95% CI 0.61 to 0.86). In 
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Table 4 Characteristics of intervention studies and their main findings: non- pharmacological treatments provided to adults at 
high risk of primary osteoporotic fracture
Authors, country, 
setting if stated
Study 
design
Population characteristics; 
number of participants for 
outcomes of interest
Intervention; healthcare 
professional if stated Main findings LoE
i) Exercise
de Kam et al53 SR Adults with osteoporosis/
osteopenia±a fracture
nine trials (n=974)
Exercise compared with 
inactive control group or 
sham intervention
Exercising <1 year had no effect on 
BMD (3/4 studies)
Exercising ≥1 year had positive effect on 
BMD/BMC (5/6 studies)
2
Luo et al30 MA Postmenopausal women with 
osteoporosis
seven trials (n=287)
Whole body vibration 
therapy compared with 
usual care
No significant difference between 
groups in change in BMD (SMD=−0.06, 
95% CI −0.22 to 0.11; p=0.05)
1
Wei et al24 MA Postmenopausal women with 
osteoporosis
two trials (n=116)
Wuqinxi exercise (mind/
body conditioning) 
compared with usual care
No significant difference in lumbar spine 
BMD at 6 months between IG and 
CG (SMD 0.81, 95% CI −0.58 to 2.20, 
p=0.25)
2
Varahra et al31 MA Adults with osteoporosis/
osteopenia±a fracture
seven trials (n=614); five trials 
(n=406)
Multicomponent exercise 
compared with non- 
exercise, usual physical 
activity and education
SMD favoured IG for mobility (−0.56, 
95% CI −0.81 to 0.32) and balance (0.5, 
95% CI 0.27 to 0.74)
1
Korpelainen et al 
Finland, community54
RCT Women with osteopenia
1.Group 1 (n=84); 2.Group 2 
(n=76)
1. Multimodal exercise 
for 12 months
2. General health 
information and usual 
care
17 fractures in the IG versus 23 fractures 
in CG at 7- year follow- up (IRR=0.68, 
95% CI 0.34 to 1.32). Similar decrease in 
BMD in IG and CG
2
Gianoudis et al 
Australia, community55
RCT Adults with osteopenia/risk of 
falls
1.Group 1 (n=81); 2.Group 2 
(n=81)
1.Multimodal exercise for 
12 months+education
2.Usual care
Exercise trainers
No significant difference in falls 
incidence between IG and CG at 1 year 
(IRR 1.22, 95% CI 0.71 to 2.04), p=0.46
2
Kemmler et al 
Germany community56
CCT
NR
Women with osteopenia
1.Group 1 (n=59); 2.Group 2 
(n=46)
1.Long- term multimodal 
exercise
2.Sedentary control group
Certified trainers
13 fractures in the IG versus 24 
fractures in the CG at 16- year follow- up 
(rate ratio=0.42; 95% CI 0.20 to 0.86; 
p=0.018)
3
ii) Nutrients including vitamin D plus calcium and oral nutritional supplements
Porter et al58 SR Postmenopausal women with 
osteopenia
three trials (n=254)
Supplementation with 
vitamin D analogues 
compared with placebo
No significant difference in mean % 
change in BMD in IG or CG when 
assessed between 6 and 12 months
1
Koutsofta et al59 SR Postmenopausal women with 
osteoporosis
five studies (n=677)
Non- soy protein (diet and/
or supplement) compared 
with a control group.
The effect of non- soy protein on BMD at 
different sites was mixed.
2
Cheung et al Canada, 
community60
RCT Postmenopausal women with 
osteopenia
1.Group 1 (n=217); 2.Group 2 
(n=223)
1. Vitamin K (5 mg) daily
2. Placebo
No significant difference in BMD 
decrease at the LS or total hip between 
IG and CG at 2 years. IG, 6 fractures; 
CG, 11 fractures
1
iii) Falls prevention programmes
Smulders et al 
The Netherlands, 
community36
RCT Adults with osteoporosis +falls 
history
1.Group 1 (n=50); 2.Group 2 
(n=46)
1. Falls prevention 
programme lasting 5.5 
weeks.
2. Usual care
Physical therapists, 
occupational therapists
Fall rate at 12 months was 39% lower in 
the IG compared with the CG (IRR 0.61, 
95% CI 0.40 to 0.94)
2
Palvanen et al Finland 
community57
RCT Older adults at high risk of 
fracture
1.Group 1 (n=661); 2.Group 2 
(n=653)
1. Individualised falls 
prevention programme
2. Brochure
Nurse, physiotherapist, 
physician
Significantly lower rate of falls at 12 
months (IRR 0.72, 95% CI 0.61 to 0.86; 
p<0.001, NNT=3). Total number of 
fractures 33 (IG) versus 42 (CG) (IRR 
0.77, 95% CI 0.48 to 1.23; p=0.276)
2
iv) Education
Morfeld et al61 SR Patients with low bone mass
four studies (n=2877)
Face- to- face patient 
education compared with 
no education or usual care
1/4 trials showed a significant between 
group difference in hip fracture 
incidence at 10- year follow- up.
2
BMC, bone mineral content; BMD, bone mineral density; CCT, controlled clinical trial; CG, control group; IG, intervention group; IRR, incidence rate 
ratio; LoE, level of evidence; LS, lumbar spine; MA, meta- analysis; NNT, number needed to treat; NR, non- randomised; RCT, randomised controlled 
trial; RR, relative risk; SMD, standardised mean difference; SR, systematic review.
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this latter study, the number of fall induced injuries was 
significantly lower in the intervention group than the 
control group (IRR 0.74, 95% CI 0.61 to 0.89; p=0.002). 
However, risk of detection bias was high in this RCT due 
to a lack of blinding of the professionals collecting falls 
data and the method of falls recording.57
Education
Evidence about the effect of patient education on bone 
health- related outcomes in people at risk of primary 
osteoporotic fracture came from one systematic review.61 
Thirteen RCTs including 5912 participants investigated 
face- to- face group, or individual educational interven-
tions delivered by HPs (nurses, community pharmacists, 
physicians, occupational therapists, dietitians, podiatrists 
and physiotherapists) working alone or in multidiscipli-
nary teams to people at risk of primary fracture. Twelve of 
the 13 studies were judged to be at high risk of detection 
bias.
The review highlighted inconsistent results across a 
range of outcomes. Less than half of the studies assessing 
initiation, receipt and use of pharmacological treatment 
for bone health showed a statistically significant difference 
between the intervention and control groups. However, 
knowledge about osteoporosis and intake of calcium 
and or vitamin D was significantly improved in the inter-
vention group compared with a control group in ≥50% 
of studies. Only one of four RCTs reporting fractures 
showed a significant reduction in fracture incidence.62 
In this study, participants in the intervention group 
received a weeklong programme of group and individual 
sessions with optional supervised gym sessions delivered 
by a multiprofessional team. Data about hip fracture inci-
dence were collected at 10 years via a national hospital 
discharge register. Following adjustment for baseline 
differences the risk of hip fracture reduced by 55%.
What is the effect of strategies undertaken by non-physician 
hPs to implement recommendations for the prevention and 
management of osteoporotic fracture by potential stakeholders?
Five primary studies in various care settings contributed 
to the evidence synthesis about the effect of strategies to 
implement recommendations by stakeholders to prevent 
and manage osteoporotic fracture (table 5). These were 
grouped into three categories: (1) strategies to increase 
implementation of recommendations; (2) multidiscipli-
nary team care and (3) interventions to enhance adher-
ence to antiosteoporosis medicines.
i. Strategies to increase implementation of recom-
mendations consisted of two or more components, 
these included: education and dissemination of 
educational materials, fall and fracture risk assess-
ment, feedback through audit and evaluation, and a 
computer- aided decision support system. The three 
cluster RCTs33 63 64 were appraised as having unclear 
risk of other bias with respect to criteria particular to 
cluster trials, for example, baseline imbalances and 
loss of clusters.21
ii. Multisiciplinary team32 care was defined as care pro-
vided by two or more different care practitioners 
working together as/or supported by a multidis-
ciplinary team. Selected publications focused on 
orthogeriatric inpatient care,32 65 fracture liaison ser-
vices (FLS)25 66 and care pathways for people follow-
ing hip fracture.67
iii. Interventions to enhance adherence to antiosteo-
porosis medicines was supported by evidence that 
suggests vitamin D and/or calcium prescribing by 
stakeholders may be increased in people at risk of 
fracture following implementation of multicompo-
nent interventions by non- physicians, such as nurs-
es, pharmacists and multiprofessional teams. Cox 
et al33 reported that supplements were 1.64 times 
more likely to be prescribed to care home residents 
in the intervention group (n=3315) over the con-
trol group (n=2322) (IRR 1.64, 95% CI 1.23 to 2.18; 
p<0.01), while Kennedy et al63 stated an absolute im-
provement of approximately 15% in vitamin D and 
7% in calcium prescribing for residents in long- term 
care following a 12- month multimodal education 
and quality improvement intervention. In one ran-
domised study set in the community,68 treatment with 
calcium and vitamin D reportedly increased by 34% 
and 13%, respectively, although this study was at high 
risk of detection bias due to unblinded outcome as-
sessors. One non- randomised study69 showed that a 
pharmacist- implemented clinical decision support 
system increased coprescription of vitamin D with a 
bisphosphonate by 29% compared with a historical 
control group. However, the effect of strategies on 
prescription of antiosteoporosis medicines was in-
conclusive, with 50% of studies reporting benefit.33 68 
There was no statistically significant difference be-
tween intervention and control groups in fractures 
and falls.
What is the effect of multidisciplinary team care on health 
outcomes for persons at high risk of primary or secondary 
osteoporotic fracture?
Available evidence (see table 5) from one meta- analysis 
and one RCT suggests that collaborative orthogeri-
atric care can reduce risk of in- hospital and long- term 
mortality, and improve mobility, activities of daily living 
and QoL compared with an ‘as needed’ geriatrician 
consult requested by the surgeon,32 or routine ortho-
paedic care65 in older adults admitted for hip fracture. 
An orthogeriatric model resulted in a 40% reduction in 
relative risk of death in hospital (relative risk 0.60, 95% CI 
0.43 to 0.84) and a 17% reduction in risk of long- term 
mortality (relative risk 0.83, 95% CI 0.74 to 0.94). In addi-
tion, data from a single RCT showed improved mobility 
at 12 months in participants receiving orthogeriatric care 
compared with usual orthopaedic care.32 However, multi-
disciplinary team care staff numbers (nurses, doctors and 
physiotherapists) per bed were higher in the geriatric 
unit than on the orthopaedic unit and the trial was at 
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d
unclear risk of detection bias due to only partial masking 
of assessors during follow- up.65 The study also identified 
that comprehensive geriatric care was more cost effec-
tive than orthopaedic care, although a lack of baseline 
EQ- 5D- 3L (3- level version of EuroQol 5 dimensions ques-
tionnaire) data precluded control of any baseline value 
imbalances.
In contrast, Leighbeg et al67 found no clear evidence of 
reduced mortality from their systematic overview of four 
secondary studies investigating the effect of care path-
ways and/or multidisciplinary team care approaches for 
people following hip fracture. However, diversity of study 
settings and difficulty with classification of studies in rela-
tion to the status of their interventions (care pathways 
or not care pathways) may have influenced the findings. 
Functional outcomes were investigated in three of the 
secondary studies with some evidence of improved func-
tional recovery when interventions involving early mobil-
isation and intensive occupational and physical therapy 
input were provided in the acute setting.
The evidence for FLS suggests that this model of care 
delivered to people presenting with different types of 
minimal trauma fracture offers significant opportunity 
for improved bone health- related outcomes compared 
with no FLS or usual care.25 Between 6 and 72 months, 
the absolute risk reduction in refracture rate in partici-
pants receiving FLS interventions compared with partic-
ipants receiving no FLS intervention or usual care was 
−0.05 (95% CI −0.08 to −0.03), equating to about a 30% 
reduction in refracture rate. The absolute risk reduction 
in mortality over the same period was −0.03 (95% CI 
−0.05 to −0.01), equating to about a 20% drop. Synthesis 
of cost- effectiveness data shows that FLS implemented 
in high- income and middle- income countries are cost 
effective irrespective of the intensity of the model and 
the country of implementation.66 One study of a FLS in 
Australia, in which a nurse coordinator assessed bone 
health in patients≥50 years of age presenting with a 
minimal trauma fracture, and subsequently referred to 
an endocrinologist, reported improved Quality Adjusted 
Life Years (QALYs) by an estimated 0.054 per patient 
(Incremental Cost Effectiveness Ratio (ICER) $A31 749) 
when treatment was prescribed over 5 years. Similarly, 
a UK nurse- led FLS delivered to patients admitted to 
hospital with a hip fracture resulted in ICERs of £19 955 
and £20 421 per QALY, thus falling within recommended 
ICER ranges.66
What is the effect of interventions provided by non-physician hPs 
to enhance adherence to antiosteoporosis medicines in adults at 
high risk of primary or secondary osteoporotic fracture?
Synthesised evidence for the effect of interventions to 
enhance adherence to and/or persistence with antiosteo-
porosis medicines included one systematic review (14 662 
participants),70 one prospective cohort study71 and one 
cluster RCT72 (table 5). Available evidence suggests that 
simplification of antiosteoporosis medication dosing 
regimens, incorporating less frequent dosing, electronic 
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prescriptions and osteoporosis management services 
provided by pharmacists, which incorporate counsel-
ling and/or monitoring of prescription redemption, 
may favourably affect medication adherence and lower 
discontinuation rates,70 71 although the amount of liter-
ature identified is limited. The effectiveness of educa-
tional interventions appears unclear.
dIsCussIOn
This SLR has appraised evidence about the effect of 
non- pharmacological interventions delivered by non- 
physician HPs to prevent and manage osteoporotic 
fractures in adults≥50 years at high risk of fracture. Our 
review showed positive effects of interventions to prevent 
and manage osteoporotic fracture despite heteroge-
neity of interventions, study designs and professions. An 
example is exercise. There is sufficient evidence that 
structured exercise, incorporating PRE, delivered to 
people following hip fracture surgery, reduces risk of 
falling. However, there is insufficient evidence to deter-
mine if structured exercise can reduce falls risk in people 
who have experienced OVF. In individuals at risk of 
primary osteoporotic fracture, there is sufficient evidence 
to support the delivery of multicomponent exercise for 
falls risk reduction and some evidence that regular multi-
component exercise interventions of at least 12 months 
duration may positively influence BMD.
There is currently insufficient evidence to support the 
effectiveness of nutrients including: daily supplementa-
tion with vitamin D plus calcium of older adults with a 
history of osteoporotic fracture; a single loading dose of 
vitamin D3 following hip fracture surgery to reduce future 
fractures and falls; vitamin D analogues and vitamin K in 
adults at risk of primary fracture on BMD, and protein 
supplementation on BMD or risk of falling in adults at 
risk of either primary or secondary fracture.
There is insufficient evidence to determine the effect 
of falls intervention initiatives on falls incidence in 
people at risk of primary or secondary osteoporotic frac-
ture, or orthoses in reducing risk of falling. Educational 
interventions delivered to patients with low bone mass by 
healthcare professionals may be generally ineffective in 
reducing fracture incidence but there is some evidence 
that education, simplification of drug regimens and 
interventions by pharmacists may improve adherence to 
antiosteoporosis medicines.
Sufficient evidence exists to show that multidisciplinary 
orthogeriatric or FLS models of care reduce mortality 
and future fractures when offered to people who have 
experienced an osteoporotic fracture, and that FLS are 
cost effective. There is some evidence that hip fracture 
care pathways may reduce risk of falling. Finally, the 
evidence about strategies undertaken by healthcare 
professionals to increase uptake of recommendations for 
the treatment and management of osteoporosis by stake-
holders, such as prescribing of vitamin D and calcium 
and antiosteoporosis medicines, is insufficient to deter-
mine if they are, or are not, effective.
This review has several limitations. First, studies 
reporting falls and fractures as primary endpoints in 
populations at high risk of osteoporotic fracture are 
limited. Our definition of ‘high risk’, based solely on BMD 
values or an expression of short- term absolute risk of frac-
ture, is likely to have excluded evidence about the effect 
of interventions on falls and fractures in other popula-
tions commonly considered at high risk of fracture, for 
example, older adults. Second, the aim of this SLR was 
to inform an international EULAR taskforce on a broad 
range of issues related to non- physician HPs’ interven-
tions. Non- physician HPs deliver different interventions 
in different countries. Therefore, we focused our review 
on interventions that could potentially be delivered by 
non- physician HPs independent of whether a study was 
led by a non- physician HP or not. The scope for further 
investigations into the role of the multidisciplinary team 
in treating osteoporotic fractures and using service link 
approaches was beyond the remit for this project, but 
deserves further inquiry. Third, our overall confidence 
rating of the results of the systematic reviews included 
in this SLR was based on reported evidence for domain- 
specific questions. Many of these systematic reviews were 
published prior to the publication of AMSTAR 2, and an 
absence of reporting may not reflect the review authors 
methods when conducting the review. Lastly, we were 
unable to answer questions 7 and 8 in our SLR. Despite 
these limitations, the process of reviewing, analysing and 
synthesising the identified evidence has been robust and 
followed EULAR guidelines for developing points to 
consider.
COnClusIOn
Existing evidence about the effect of non- pharmacological 
interventions on reducing fractures in people at high risk 
of osteoporotic fracture is limited. Despite study heter-
ogeneity, our SLR showed beneficial effects of some 
interventions delivered by non- physician HPs and the 
positive impact of multidisciplinary team working and 
sound patient educational approaches to prevent and 
manage osteoporotic fractures. These results informed a 
EULAR taskforce that developed points to consider for 
non- physician HPs to prevent and manage osteoporotic 
fractures in adults 50 years or more.
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